Clinical Trials

Limited scleroderma

Displaying 4 studies

Belumosudil In Subjects With Diffuse Cutaneous Systemic Sclerosis Scottsdale/Phoenix, AZ

The purpose of this study is to evaluate the effectiveness and safety of KD025 to treat Diffuse Cutaneous Systemic Sclerosis.
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis Rochester, MN

The purpose of this study is to assess the safety and effectiveness of subcutaneous abatacept in patients with diffuse cutaneous systemic sclerosis.
A Study to Evaluate Cardiopulmonary Complications in Systemic Sclerosis Rochester, MN

The purpose of this study is to assess whether our not the percentage of pulmonary related vascular structures (PRVS) determined by the quantitative CT (Q-CT) tool CALIPER is a novel measure that can be used for the early detection of pulmonary vascular remodeling in patients with SSc. pulmonary related vascular structures
A Study Of Inhaled GB002 For Treatment Of WHO Group I Pulmonary Arterial Hypertension Jacksonville, FL

The purpose of this study is to evaluate the safety, pharmacokinetics (PK), pharmacodynamics (PD), and biomarkers of inhaled GB002 in adults with World Health Organization (WHO) Group 1 Pulmonary Arterial Hypertension (PAH).